C-Peptide Test: Normal Range

Quick answer

The C-peptide test shows how much insulin your pancreas is actually making; normal fasting is 0.5-2.0 ng/mL. Low C-peptide with high glucose suggests type 1 diabetes, while normal or high C-peptide with high glucose suggests insulin resistance and type 2. It also separates body-made insulin from injected insulin when investigating low blood sugar.

What Is C-Peptide?

C-peptide is released in equal amounts to insulin when your pancreas produces it. Measuring C-peptide shows how much insulin your body is actually making, even if you are taking insulin injections.

Normal C-Peptide Range

Test	Normal Range
Fasting C-peptide	0.5–2.0 ng/mL
Fasting Insulin (paired)	2–25 µIU/mL

Key points

C-peptide is released in equal amounts to insulin when the pancreas makes it, so it shows how much insulin the body is actually producing, even during insulin injections.
Low C-peptide with high glucose suggests type 1 (or advanced type 2) diabetes; normal or high C-peptide with high glucose suggests insulin resistance and type 2.
It is central to working up unexplained hypoglycaemia: high C-peptide points to excess body-made insulin (possible insulinoma or diabetes tablets), while low C-peptide with high insulin suggests injected insulin.
Main uses: distinguishing diabetes type when unclear, evaluating hypoglycaemia, assessing pancreatic reserve, and monitoring insulinoma.
It is interpreted alongside glucose and insulin levels, not alone.

Why It's Ordered

Distinguishing Type 1 from Type 2 diabetes
Evaluating unexplained low blood sugar (hypoglycaemia)
Assessing pancreatic insulin-producing capacity
Monitoring insulinoma (insulin-producing tumour)

What Low C-Peptide Means

Low levels suggest the pancreas is making little or no insulin: typical in Type 1 diabetes or advanced Type 2 diabetes.

What High C-Peptide Means

High levels suggest the pancreas is overproducing insulin, seen in early Type 2 diabetes, insulin resistance, or rarely an insulinoma.

C-peptide at a glance: the compiled numbers

C-peptide is most useful read together with glucose and insulin — the pattern across the three is the diagnosis. Here are the typical pieces:

Measure	Typical adult reference range*	What it tells you
C-peptide (fasting)	Roughly 0.8–3.1 ng/mL	How much insulin your own pancreas is making — it is released 1:1 with insulin
Insulin (fasting)	Roughly 2–25 µIU/mL	Circulating insulin — but injected insulin confuses this test, not C-peptide
Low C-peptide + high glucose	Pattern	Pancreas making too little insulin — the type 1 diabetes pattern
High C-peptide + high glucose	Pattern	Pancreas making plenty but the body resisting it — the type 2 / insulin-resistance pattern
Typical cost	&rupee;700–&rupee;1,400	Often ordered with fasting glucose and insulin; prices vary by city and lab

*Ranges vary between labs and assays — the interval printed on your own report governs. Prices are approximate bands, not quotes.

C-peptide myths vs facts

C-peptide is a clever test that gets dumbed down into “high is bad, low is good.” Here is what it actually says:

MYTH C-peptide is just another name for insulin.

Fact: They are released together, but C-peptide lasts longer in blood and — crucially — is not present in injected insulin. That makes it the honest measure of what your own pancreas is producing, even in someone taking insulin shots.

MYTH You can't test C-peptide if you're on insulin.

Fact: You can — that is rather the point. Because injected insulin contains no C-peptide, the test still reflects your pancreas's own output. It is one of the few diabetes tests that stays interpretable on insulin therapy.

MYTH A high C-peptide is always bad.

Fact: High C-peptide with high glucose usually means insulin resistance — the pancreas working overtime. But high C-peptide with normal glucose can be an appropriate response to a recent meal. Context decides.

MYTH Fasting is optional for C-peptide.

Fact: Meals raise C-peptide substantially, so fasting samples are the standard for interpretation. A non-fasting value is hard to read — note the timing if the draw wasn't fasting.

What matters most with your C-peptide result

Read it with glucose, not alone. The same C-peptide means opposite things with normal versus high glucose — the pair is the interpretation.
It separates the diabetes types. Very low C-peptide points toward insulin deficiency (type 1 pattern); high C-peptide toward resistance (type 2 pattern) — which is why doctors order it when the type is unclear.
Insulin therapy doesn't spoil it. Unlike the insulin test, C-peptide stays meaningful on insulin shots — mention your medicines so the pattern is read correctly.
Fasting matters. A non-fasting C-peptide is difficult to interpret; if the draw wasn't fasting, say so rather than worrying about the number. Discuss the full picture with your doctor.

Frequently Asked Questions

Can I take a C-peptide test if I'm already on insulin?

Yes. That's one of its main strengths. Because C-peptide reflects only your body's own insulin production (injected insulin contains no C-peptide), it can reveal how much natural insulin you still make even while on injections.

What does a high C-peptide level mean?

High C-peptide usually indicates your pancreas is producing large amounts of insulin, which is common in type 2 diabetes with insulin resistance, obesity, or, rarely, an insulin-producing tumour (insulinoma).

Do I need to fast before a C-peptide test?

Often yes: a fasting sample (8–12 hours) is standard, sometimes paired with a glucose reading. Your clinic will tell you if a stimulated (post-meal) test is needed instead.

Do I need to fast for a C-peptide test?

Usually yes — 8 to 12 hours of fasting, following your lab's instruction. A glucose sample is drawn at the same time, because the two results are interpreted together.

What is the difference between C-peptide and insulin tests?

An insulin test measures all insulin in your blood, including injected insulin. C-peptide measures only what your own pancreas makes, which is why it is used to judge remaining insulin production.

Can C-peptide tell type 1 from type 2 diabetes?

It helps: low C-peptide with high glucose suggests insulin deficiency (the type 1 pattern), while high C-peptide suggests insulin resistance (the type 2 pattern). But diabetes type is diagnosed from the full clinical picture, not one test — discuss it with your doctor.

Why is my C-peptide high but my sugar normal?

This often reflects early insulin resistance: the pancreas is making extra insulin to keep glucose normal. It is a signal worth discussing with your doctor, not a diagnosis on its own.

How much does the C-peptide test cost in India?

The C-peptide test typically costs ₹700–₹1,400 in India, though prices vary by city and lab. Choose a NABL-accredited lab where possible — and remember the reference range printed on your own report is the one that counts. Discuss the result with your doctor.

How C-peptide is used in practice

The main clinical value of C-peptide is distinguishing between types of diabetes when the picture is unclear, for example in a younger adult who could have late-onset type 1 or early type 2 diabetes. A low C-peptide alongside high glucose indicates the pancreas is producing little insulin, supporting type 1; a normal or high result with high glucose suggests insulin resistance, supporting type 2.

It is also central to investigating unexplained low blood sugar. If someone has hypoglycaemia with a high C-peptide, their body is producing excess insulin, which raises the possibility of an insulin-producing tumour or the effect of certain diabetes tablets. If C-peptide is low while insulin is high, this suggests insulin has come from an injection rather than from the pancreas.

Pharmacist's practical notes

C-peptide's party trick — staying honest while you're on insulin — is also its commonest source of confusion: people assume insulin therapy invalidates the test, when it is precisely the test that survives it. If you're on insulin, make sure the lab knows; the interpretation changes, not the validity.

Because meals move C-peptide, the fasting instruction matters more here than for many tests. And when the result sorts type 1 from type 2 patterns, the treatment implications diverge completely — which is why this result should travel straight to your doctor, not to internet pattern-matching.

In India

Indian labs usually report C-peptide in ng/mL (a few use nmol/L). The test typically costs &rupee;700–&rupee;1,400, though prices vary by city and lab; it is commonly ordered alongside fasting glucose and insulin.

Where possible, choose a NABL-accredited lab. Assays differ between labs, so the range printed on your own report is the one that governs.

References

Sources cited on this page. PubMed links open the original abstract.

Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med. 2013;30(7):803–817. PMID 23413806 · doi:10.1111/dme.12159
Sacks DB, Arnold M, Bakris GL, et al. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes Care. 2023;46(10):2707–2741. PMID 37471273 · doi:10.2337/dci23-0036
Forlenza GP, McVean J, Beck RW, et al. Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes. JAMA. 2023;329(12):990–1000. PMID 36826844 · doi:10.1001/jama.2023.2064

What C-peptide measures and why it matters

C-peptide (connecting peptide) is a 31-amino acid fragment cleaved from proinsulin when the pancreas produces insulin. One molecule of C-peptide is produced for every molecule of insulin. Because C-peptide is released in equimolar amounts with insulin, its blood level is a direct measure of how much insulin the pancreas is making.

The key clinical advantage of C-peptide over measuring insulin directly: injected insulin does not contain C-peptide, and the liver does not clear C-peptide as rapidly as insulin. This means:

C-peptide accurately reflects endogenous (the body's own) insulin production, even in patients taking exogenous insulin injections
C-peptide has a longer half-life in blood (approximately 30 minutes versus 4 minutes for insulin), making it easier to measure reliably

Clinical uses of C-peptide testing

Distinguishing type 1 from type 2 diabetes: Type 1 diabetes destroys insulin-producing beta cells, C-peptide falls to undetectable or very low levels (below 0.2 nmol/L). Type 2 diabetes involves insulin resistance with initially preserved or high C-peptide production. This distinction matters when insulin dependence is unclear, particularly in Latent Autoimmune Diabetes in Adults (LADA), which presents like type 2 diabetes but has low C-peptide and positive islet antibodies (anti-GAD, anti-ZnT8).²
Hypoglycaemia investigation: C-peptide is critical in the hypoglycaemia workup. During a hypoglycaemic episode, an elevated C-peptide alongside high insulin suggests the insulin is coming from the patient's own pancreas, raising suspicion for insulinoma (insulin-secreting pancreatic tumour) or sulfonylurea misuse. Suppressed C-peptide with high insulin in hypoglycaemia indicates exogenous insulin administration, factitious hypoglycaemia (someone self-administering insulin without medical indication).
Monitoring residual beta-cell function: In type 1 diabetes, residual C-peptide production (even at low levels) is associated with better glycaemic control, fewer hypoglycaemic episodes, and reduced long-term complications. Clinical trials of beta-cell preservation therapies (teplizumab, baricitinib, verapamil) use C-peptide as a primary endpoint.³
Post-pancreatectomy assessment: After pancreatic surgery, C-peptide confirms whether sufficient beta-cell mass remains to avoid insulin dependence.

How C-peptide is measured, practical points

C-peptide is measured on a fasting blood sample or during a mixed-meal stimulation test (a standardised liquid meal that provokes maximal insulin secretion). A random or fasting C-peptide below 0.2 nmol/L in a person with diabetes suggests complete beta-cell failure (type 1 / LADA). A stimulated C-peptide above 0.6 nmol/L indicates significant residual insulin secretion. Results must always be interpreted alongside blood glucose at the time of sampling, a C-peptide of 0.5 nmol/L is appropriately suppressed with a glucose of 3.0 mmol/L but inappropriately elevated at hypoglycaemic levels.

Important: C-peptide results must be interpreted alongside blood glucose levels and clinical history by your doctor.